Cargando…

Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor

Patients with neuroendocrine malignancy with liver metastases are at risk for carcinoid heart disease which, if left unchecked, can lead to heart failure. This case study demonstrates a clinical situation in which an advanced practitioner performed a thorough workup consisting of lab work and imagin...

Descripción completa

Detalles Bibliográficos
Autores principales: Henderson, Amy, Al Mutar, Salwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258855/
https://www.ncbi.nlm.nih.gov/pubmed/37313280
http://dx.doi.org/10.6004/jadpro.2023.14.4.8
_version_ 1785057549525975040
author Henderson, Amy
Al Mutar, Salwan
author_facet Henderson, Amy
Al Mutar, Salwan
author_sort Henderson, Amy
collection PubMed
description Patients with neuroendocrine malignancy with liver metastases are at risk for carcinoid heart disease which, if left unchecked, can lead to heart failure. This case study demonstrates a clinical situation in which an advanced practitioner performed a thorough workup consisting of lab work and imaging studies, including echocardiogram, cardiac MRI, and dotatate PET/CT, as well as outside record review and comprehensive physical exam. Early detection, intervention, and control of disease are paramount to prevent potentially life-limiting carcinoid heart disease.
format Online
Article
Text
id pubmed-10258855
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-102588552023-06-13 Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor Henderson, Amy Al Mutar, Salwan J Adv Pract Oncol Diagnostic Snapshot Patients with neuroendocrine malignancy with liver metastases are at risk for carcinoid heart disease which, if left unchecked, can lead to heart failure. This case study demonstrates a clinical situation in which an advanced practitioner performed a thorough workup consisting of lab work and imaging studies, including echocardiogram, cardiac MRI, and dotatate PET/CT, as well as outside record review and comprehensive physical exam. Early detection, intervention, and control of disease are paramount to prevent potentially life-limiting carcinoid heart disease. Harborside Press LLC 2023-05 2023-05-01 /pmc/articles/PMC10258855/ /pubmed/37313280 http://dx.doi.org/10.6004/jadpro.2023.14.4.8 Text en © 2023 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Diagnostic Snapshot
Henderson, Amy
Al Mutar, Salwan
Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
title Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
title_full Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
title_fullStr Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
title_full_unstemmed Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
title_short Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
title_sort heart failure in a patient with metastatic well-differentiated neuroendocrine tumor
topic Diagnostic Snapshot
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258855/
https://www.ncbi.nlm.nih.gov/pubmed/37313280
http://dx.doi.org/10.6004/jadpro.2023.14.4.8
work_keys_str_mv AT hendersonamy heartfailureinapatientwithmetastaticwelldifferentiatedneuroendocrinetumor
AT almutarsalwan heartfailureinapatientwithmetastaticwelldifferentiatedneuroendocrinetumor